Prevalence of ecosapentaenoic acid and docosahexaenoic acid deficiency in pregnant women: a prospective observational study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20233632Keywords:
Ecosapentaenoic acid, Docosahexaenoic acid, Omega 3 indexAbstract
Background: Docosahexaenoic acid (DHA), ecosapentaenoic acid (EPA) and alpha lineoloic acid (α-LA) are essential fatty acids of the long chain polyunsaturated fatty acid (LC-PUFA) or omega-3 fatty acid. These fatty acids are not synthesized by our body. Diets rich in LC-PUFA reduces the incidence of - preeclampsia, intrauterine growth restriction, preterm delivery, in utero fetal death and placental abruption. Objectives of the study were: to estimate the prevalence of EPA and DHA deficiency in pregnant women by omega-3 index test (O3I), and also to correlate blood levels of EPA and DHA with various socio demographic parameters.
Methods: All enrolled subjects were assessed with a pre-defined performa for their demographic and socio-economic characteristics, personal history, obstetric history, body mass index (BMI), education, diet and blood samples were tested for O3I.
Results: Result of the study indicated that 98% of pregnant women had EPA and DHA deficiency as indicated by O3I levels. This was regardless of age, parity, BMI, and socio economic status. Women consuming vegetarian diet had statistically significant lower mean and median levels of O3I as compared to the women having a non-vegetarian diet, p value <0.001, 0.004 respectively. In our entire cohort of 150 women, only 2 non-vegetarian women had sufficient O3I.
Conclusions: 98% of pregnant women across various socio economic classes had EPA and DHA deficiency as measured by O3I levels. Vegetarians had statistically significant lower levels of O3I as compared to the non-vegetarians.
Metrics
References
Ratnayake WM, Galli C. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab. 2009;55:8-43.
Jung UJ, Torrejon C, Tighe AP, Deckelbaum RJ. N-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr. 2008;87:2003S-9S.
Uauy R, Dangour AD. Fat and fatty Acid requirements and recommendations for infants of 0–2 Years and children of 2–18 Years. Ann Nutr Metab. 2009;55:76-96.
Innis SM. Essential fatty acid transfer and fetal development. Placenta. 2005;26:S70-5.
Oken E, Ning YI, Rifas-Shiman SL. Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol. 2007;17:663-8.
Khong Y, Brosens I. Defective deep placentation. Best Pract Res Clin Obstet Gynaecol. 2011;25:301-11.
Romero R, Kusanovic JP, Chaiworapongsa T. Placental bed disorders in preterm labour, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol. 2011;25:313-27.
Healy-Stoffel M, Levant B. N-3 (omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets. 2018;17:216-32.
Costantini L, Molinari R, FarinonB, Merendino N. Impact of omega-3 fatty acids on the gut microbiota. Int J Mol Sci. 2017;18:2645-63.
Stokholm J, Blaser MJ, Thorsen J, Rasmussen MA, Waage J, Vinding RK, et al. Maturation of the gut microbiome and risk of asthma in childhood. Nat Commun. 2018;9:141-51.
Hubinont C, Savoye T. Maternal and fetal benefits of DHA supplementation during pregnancy. J Pregnancy Reprod. 2017;1:1-7.
Braarud HC, Markhus MW, Skotheim S, Stormark KM, Frøyland L, Graff IE, et al. Maternal DHA Status during pregnancy has a positive impact on infant problem solving: A Norwegian prospective observation study. Nutrients. 2018;10:529-41.
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, et al. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy. 2003;33:442-8.
LISA Study Group, Sausenthaler S, Koletzko S, Schaaf B, Lehmann I, et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2y of age. Am J Clin Nutr. 2007;85:530-7.
Flock MR, Skulas-Ray AC, Harris WS, Etherton TD, Fleming JA, Kris-Etherton PM. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: A dose-response randomized controlled trial. J Am Heart Assoc. 2013;2:e000513.
Christian LM, Blair LM, Porter K, Lower M, Cole RM, Belury MA. Polyunsaturated Fatty Acid (PUFA) status in pregnant women: associations with sleep quality, inflammation, and length of gestation. PLoS One. 2016;11:e0148752.
Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N Jr. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res. 2016;63:132-52.
Greenberg JA, Bell SJ. Omega-3 fatty acid supplementation during pregnancy. Rev Obstet Gynecol. 2008;1:162-9.
Jackson KH, Harris WS. A prenatal DHA test to help identify women at increased risk for early preterm birth: A proposal. Nutrient. 2018;10:1933-45.
World Health Organization. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. World Health Organization. 2003.
Khandelwal S, Kondal D, Chaudhary M, Patil K, Metgud D, Joglekar S, et al. Maternal Docosahexaenoic Acid (DHA) Supplementation and Offspring Neurodevelopment in India (DHANI). Curr Dev Nutr. 2020;4:3041-56.
Basak S, Mallick R, Duttaroy AK. Maternal Docosahexaenoic Acid Status during Pregnancy and Its Impact on Infant Neurodevelopment. Nutrients. 2020;12:3615-40.
Kumari SS. From The Desk of President FOGSI Dr S. Shantha Kumari. J Obstet Gynaecol India. 2021;1-8.
Young IE, Parker HM, Cook RL, O’dwyer NJ, Garg ML, Steinbeck KS, et al. Association between Obesity and Omega-3 Status in Healthy Young Women. Nutrients. 2020;12:1480-90.
Saunders AV, Davis BC, Garg ML. Omega-3 polyunsaturated fatty acids and vegetarian diets. Med J Aust. 2013;199:22-6.